Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is 16% above its 5-year average of 86.12%, near the high end of its 5-year range (0.00%–100.00%).
66.67% above its 12-month average of 60.00%.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-05-31): 0.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
60.00%
GROSS MARGIN AVG 3Y
99.53%
GROSS MARGIN AVG 5Y
86.12%
GROSS MARGIN AVG 10Y
82.35%
GROSS MARGIN AVG 15Y
55.90%
GROSS MARGIN AVG 20Y
42.88%
CURRENT VS TTM AVG
+66.67%
CURRENT VS 3Y AVG
+0.47%
CURRENT VS 5Y AVG
+16.11%
CURRENT VS 10Y AVG
+21.44%
CURRENT VS 15Y AVG
+78.89%
CURRENT VS 20Y AVG
+133.19%
SECTOR MEDIAN · HEALTHCARE
40.63%
median of 726 covered companies
CURRENT VS SECTOR MEDIAN
+146.12%
vs the sector median at left
Lexaria Bioscience Corp.
Market Cap
$4.77M
Gross Margin
100.00%
TTM Avg
60.00%
3Y Avg
99.53%
5Y Avg
86.12%
Market Cap
$4.64M
Gross Margin
19.34%
TTM Avg
59.23%
3Y Avg
54.62%
5Y Avg
36.41%
Market Cap
$4.58M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.34M
Gross Margin
26.32%
TTM Avg
-195.38%
3Y Avg
-178.16%
5Y Avg
-96.97%
Market Cap
$4.50M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.15M
Gross Margin
77.68%
TTM Avg
77.66%
3Y Avg
77.69%
5Y Avg
77.69%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $4.77M | 100.00% | 60.00% | 99.53% | 86.12% |
| CalciMedica, Inc. (CALC)vs › | $4.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.64M | 19.34% | 59.23% | 54.62% | 36.41% |
| Imunon, Inc. (IMNN)vs › | $5.08M | 0.00% | 0.00% | 25.00% | 50.00% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.34M | 26.32% | -195.38% | -178.16% | -96.97% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.15M | 77.68% | 77.66% | 77.69% | 77.69% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.17M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-05-31 | 0.00% |
| 2026-02-28 | 100.00% |
| 2025-11-30 | 0.00% |
| 2025-08-31 | 100.00% |
| 2025-05-31 | 100.00% |
| 2025-02-28 | 100.00% |
| 2024-11-30 | 98.52% |
| 2024-08-31 | 100.00% |
| 2024-05-31 | 100.00% |
| 2024-02-29 | 100.00% |
| 2023-11-30 | 96.81% |
| 2023-08-31 | 100.00% |
| 2023-05-31 | 83.60% |
| 2023-02-28 | 85.23% |
| 2022-11-30 | 83.84% |
| 2022-08-31 | 62.89% |
| 2022-05-31 | 81.31% |
| 2022-02-28 | 79.16% |
| 2021-11-30 | 59.87% |
| 2021-08-31 | 34.53% |
| 2021-05-31 | 70.60% |
| 2021-02-28 | 84.08% |
| 2020-11-30 | 78.19% |
| 2020-08-31 | 90.20% |
| 2020-05-31 | 44.21% |
| 2020-02-29 | -54.75% |
| 2019-11-30 | 23.99% |
| 2019-08-31 | 88.05% |
| 2019-05-31 | 94.83% |
| 2019-02-28 | 82.47% |
| 2018-11-30 | 90.28% |
| 2018-08-31 | 96.94% |
| 2018-05-31 | 98.27% |
| 2018-02-28 | 92.03% |
| 2017-11-30 | 75.24% |
| 2017-08-31 | 61.72% |
| 2017-05-31 | 68.61% |
| 2017-02-28 | -18.01% |
| 2016-11-30 | 90.37% |
| 2016-08-31 | 68.63% |
| 2016-05-31 | -49.78% |
| 2016-02-29 | -26.94% |
| 2015-11-30 | -33.34% |
| 2015-08-31 | -291.62% |
| 2015-05-31 | -34.84% |
| 2015-02-28 | 28.82% |
| 2014-11-30 | 0.00% |
| 2014-07-31 | 39.57% |
| 2014-04-30 | 34.28% |
| 2014-01-31 | 20.85% |
| 2013-10-31 | 3.93% |
| 2013-07-31 | 30.28% |
| 2013-04-30 | 34.84% |
| 2013-01-31 | 36.51% |
| 2012-10-31 | 43.38% |
| 2012-07-31 | 53.62% |
| 2012-04-30 | 1.18% |
| 2012-01-31 | 41.77% |
| 2011-10-31 | 128.98% |
| 2011-07-31 | 53.21% |
| 2011-04-30 | 26.36% |
| 2011-01-31 | 19.48% |
| 2010-10-31 | 42.53% |
| 2010-07-31 | 32.28% |
| 2010-04-30 | -21.22% |
| 2010-01-31 | 2.23% |
| 2009-10-31 | -29.57% |
| 2009-07-31 | 8.56% |
| 2009-04-30 | -79.18% |
| 2009-01-31 | -43.24% |
| 2008-10-31 | -222.21% |
| 2008-07-31 | 39.10% |
| 2008-04-30 | 8.55% |
| 2008-01-31 | 26.88% |
| 2007-10-31 | 982.38% |
| 2007-07-31 | -726.65% |
| 2007-04-30 | -114.64% |
| 2007-01-31 | -1007.08% |
| 2006-10-31 | 0.00% |
| 2006-07-31 | 0.00% |
| 2006-04-30 | 0.00% |
| 2006-01-31 | 0.00% |
